Evidence Review
Aspalathin and Metabolic Health
Johnson et al. (2018) provided a comprehensive review of aspalathin's therapeutic potential for metabolic syndrome [3]. The compound has demonstrated multiple relevant mechanisms in preclinical models:
- Glucose uptake: Aspalathin increases glucose uptake in muscle cells via AMPK activation, independent of insulin signaling.
- Insulin secretion: It enhances glucose-stimulated insulin secretion from pancreatic beta cells.
- Lipid metabolism: Aspalathin suppresses hepatic lipogenesis and reduces triglyceride accumulation.
- Anti-inflammatory: It attenuates NF-kB-mediated inflammation in adipose tissue.
These effects have been demonstrated primarily in cell culture and rodent models. While the mechanistic evidence is robust, human clinical trials specifically testing aspalathin supplementation are still limited. The metabolic effects observed with whole rooibos tea consumption [4] may be attributable to aspalathin working synergistically with other rooibos flavonoids.
Cardiovascular Evidence
The Marnewick et al. (2011) trial is the most cited human study on rooibos [4]. Forty adults at risk for heart disease consumed six cups of rooibos daily for six weeks in a controlled study. Key findings:
- LDL cholesterol decreased significantly (p < 0.001)
- Triglycerides decreased significantly
- HDL cholesterol increased significantly
- Plasma conjugated dienes (a marker of lipid peroxidation) decreased
- Glutathione (an endogenous antioxidant) levels improved
The effect sizes were clinically meaningful, comparable to moderate dietary interventions. However, six cups per day represents high consumption, and whether lower doses produce proportional benefits is unknown.
Bioavailability Considerations
Joubert and de Beer (2011) addressed the critical question of whether rooibos compounds are bioavailable when consumed as tea [1][2]. Aspalathin is absorbed in the gut and detectable in plasma, but its bioavailability is relatively low. However, metabolites of aspalathin may retain biological activity, and the consistent results from whole-tea studies suggest that sufficient quantities reach target tissues at typical consumption levels.
Notably, unfermented ("green") rooibos retains significantly more aspalathin than the traditional fermented ("red") rooibos. The fermentation process oxidizes much of the aspalathin. For those seeking maximum antioxidant benefit, green rooibos is the better choice, though fermented rooibos still contains meaningful amounts of bioactive compounds [2].
Limitations
The evidence base for rooibos health effects is smaller than for green or black tea. Most mechanistic work comes from a concentrated group of South African research institutions, and independent replication would strengthen the findings. Human trials are few and generally small. The bone health and allergy claims rest on preclinical evidence and traditional use rather than clinical data.
Rooibos is considered very safe. No significant adverse effects have been reported in clinical studies or from its long history of consumption in South Africa. Rare case reports of hepatotoxicity exist but have not established causation, and the overall safety profile is reassuring [1].